VANCOUVER, BC--(Marketwire - December 06, 2007) - TapImmune Inc. (OTCBB: TPIM) (the "Company"), a biotechnology company specializing in the development of immunotherapeutics for cancer and vaccines for infectious diseases, today announced the USPTO has granted its petition to revive the U.S. Pat. Appln No. 10/046,542.
